Cambrium
Berlin
About Cambrium
Cambrium's mission is to trigger the next wave of material innovation by harnessing nature’s protein building blocks. Our platform combines synthetic biology, machine learning and lab automation to create high-performance materials at scale. We fundamentally believe that the ability to align economic and environmental incentives makes biology the most important manufacturing technology of the 21st century. We are accelerating a Cambrian explosion of biomaterials to address the world’s most pressing problems.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $8.5M
- Funding stage: Seed
- Last round: Seed (Jun 2024)
- Website: cambrium.bio
- Phone: [email protected]
Industries & Categories
Advanced Materials, Bioinformatics, Biotechnology, Machine Learning, Robotics
Social Profiles
Canonical: https://fsome.com/organization/cambrium-62559 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.